We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Reneuron Group Plc | LSE:RENE | London | Ordinary Share | GB00BF5G6K95 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 3.05 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 530k | -5.41M | -0.0946 | -0.32 | 1.74M |
From Apr 2019 to Apr 2024
TIDMRENE
RNS Number : 9582V
ReNeuron Group plc
11 April 2019
11 April 2019 AIM: RENE
ReNeuron Group plc
("ReNeuron" or the "Company")
Share Purchases by Directors
ReNeuron Group plc (AIM: RENE), a UK-based global leader in the development of cell-based therapeutics, was informed on 11 April 2019 that, on the same day, the following purchases of the Company's ordinary shares of 1p each ("Ordinary Shares") were made by directors of the Company:
Hot Features
Premium
Name Title Number Total beneficial Percentage
of Ordinary interest in of Company's
Shares the Company's Total Voting
purchased Ordinary Shares Rights
Non-executive
John Berriman Chairman 80,000 90,434 0.286
--------------- ------------- ----------------- --------------
Simon Cartmell Non-executive
OBE Director 7,758 15,633 0.049
--------------- ------------- ----------------- --------------
Professor
Sir Chris Non-executive
Evans OBE Director 4,500 244,605 0.773
--------------- ------------- ----------------- --------------
Non-executive
Dr Mike Owen Director 4,237 4,237 0.013
--------------- ------------- ----------------- --------------
S
ENQUIRIES:
ReNeuron +44 (0)20 3819 8400 Olav Hellebø , Chief Executive Officer Michael Hunt, Chief Financial Officer Buchanan +44 (0) 20 7466 5000 Mark Court, Sophie Wills, Tilly Abraham Stifel Nicolaus Europe Limited +44 (0) 20 7710 7600 Jonathan Senior, Stewart Wallace, Ben Maddison (NOMAD and Joint Broker) Nplus1 Singer Advisory LLP +44 (0) 20 7496 3000 Aubrey Powell, Mark Taylor (Joint Broker)
About ReNeuron
ReNeuron is a global leader in cell-based therapeutics, harnessing its unique stem cell technologies to develop 'off the shelf' stem cell treatments, without the need for immunosuppressive drugs. The Company's lead clinical-stage candidates are in development for disability as a result of stroke and for the blindness-causing disease, retinitis pigmentosa. ReNeuron is also advancing its proprietary exosome technology platform as a potential delivery system for drugs that would otherwise be unable to reach their site of action. ReNeuron's shares are traded on the London AIM market under the symbol RENE.L. For further information visit www.reneuron.com.
The notifications below, made in accordance with the requirements of the EU Market Abuse Regulation, provide further detail:
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name John Berriman
------------------------------------------------------------ ---------------------------------
2 Reason for the notification
-----------------------------------------------------------------------------------------------
a) Position/status Non-Executive Chairman
------------------------------------------------------------ ---------------------------------
b) Initial notification /Amendment Initial notification
------------------------------------------------------------ ---------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-----------------------------------------------------------------------------------------------
a) Name ReNeuron Group plc
------------------------------------------------------------ ---------------------------------
b) LEI 2138003TU12CQ5TZO137
------------------------------------------------------------ ---------------------------------
4 Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii)
each date; and (iv) each place where transactions have been conducted
-----------------------------------------------------------------------------------------------
a) Description of the financial instrument, type of instrument Ordinary Shares 1p
Identification code RENE - GB00BF5G6K95
------------------------------------------------------------ ---------------------------------
b) Nature of the transaction Purchase of ordinary shares
------------------------------------------------------------ ---------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
225p 80,000
----------
------------------------------------------------------------ ---------------------------------
d) Aggregated information N/A
------------------------------------------------------------ ---------------------------------
e) Date of the transaction 11 April 2019
------------------------------------------------------------ ---------------------------------
f) Place of the transaction London Stock Exchange AIM Market
------------------------------------------------------------ ---------------------------------
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Simon Cartmell OBE
------------------------------------------------------------ ---------------------------------
2 Reason for the notification
-----------------------------------------------------------------------------------------------
a) Position/status Non-Executive Director
------------------------------------------------------------ ---------------------------------
b) Initial notification /Amendment Initial notification
------------------------------------------------------------ ---------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-----------------------------------------------------------------------------------------------
a) Name ReNeuron Group plc
------------------------------------------------------------ ---------------------------------
b) LEI 2138003TU12CQ5TZO137
------------------------------------------------------------ ---------------------------------
4 Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii)
each date; and (iv) each place where transactions have been
conducted
-----------------------------------------------------------------------------------------------
a) Description of the financial instrument, type of instrument Ordinary Shares 1p
Identification code RENE - GB00BF5G6K95
------------------------------------------------------------ ---------------------------------
b) Nature of the transaction Purchase of ordinary shares
------------------------------------------------------------ ---------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
225.5516p 7,758
----------
------------------------------------------------------------ ---------------------------------
d) Aggregated information N/A
------------------------------------------------------------ ---------------------------------
e) Date of the transaction 11 April 2019
------------------------------------------------------------ ---------------------------------
f) Place of the transaction London Stock Exchange AIM Market
------------------------------------------------------------ ---------------------------------
Details of the person discharging managerial responsibilities
1 / person closely associated
a) Name Professor Sir Chris Evans OBE
-------------------------------- ---------------------------------------
2 Reason for the notification
-------------------------------------------------------------------------
a) Position/status Non-Executive Director
-------------------------------- ---------------------------------------
b) Initial notification Initial notification
/Amendment
-------------------------------- ---------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-------------------------------------------------------------------------
a) Name ReNeuron Group plc
-------------------------------- ---------------------------------------
b) LEI 2138003TU12CQ5TZO137
-------------------------------- ---------------------------------------
4 Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii)
each date; and (iv) each place where transactions have been conducted
-------------------------------------------------------------------------
a) Description of Ordinary Shares 1p
the financial instrument, RENE - GB00BF5G6K95
type of instrument
Identification
code
-------------------------------- ---------------------------------------
b) Nature of the transaction Purchase of ordinary shares
-------------------------------- ---------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
221.5p 4,500
----------
-------------------------------- ---------------------------------------
d) Aggregated information N/A
-------------------------------- ---------------------------------------
e) Date of the transaction 11 April 2019
-------------------------------- ---------------------------------------
f) Place of the transaction London Stock Exchange AIM Market
-------------------------------- ---------------------------------------
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Dr Mike Owen
-------------------------------- ---------------------------------------
2 Reason for the notification
-------------------------------------------------------------------------
a) Position/status Non-Executive Director
-------------------------------- ---------------------------------------
b) Initial notification Initial notification
/Amendment
-------------------------------- ---------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-------------------------------------------------------------------------
a) Name ReNeuron Group plc
-------------------------------- ---------------------------------------
b) LEI 2138003TU12CQ5TZO137
-------------------------------- ---------------------------------------
4 Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii)
each date; and (iv) each place where transactions have been conducted
-------------------------------------------------------------------------
a) Description of Ordinary Shares 1p
the financial instrument, RENE - GB00BF5G6K95
type of instrument
Identification
code
-------------------------------- ---------------------------------------
b) Nature of the transaction Purchase of ordinary shares
-------------------------------- ---------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
236p 4,237
----------
-------------------------------- ---------------------------------------
d) Aggregated information N/A
-------------------------------- ---------------------------------------
e) Date of the transaction 11 April 2019
-------------------------------- ---------------------------------------
f) Place of the transaction London Stock Exchange AIM Market
-------------------------------- ---------------------------------------
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
DSHZMGMDKMRGLZM
(END) Dow Jones Newswires
April 11, 2019 11:31 ET (15:31 GMT)
1 Year Reneuron Chart |
1 Month Reneuron Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
